UK Markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.62-0.51 (-5.59%)
At close: 04:00PM EDT
8.34 -0.26 (-3.02%)
After hours: 04:19PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts6677
Avg. Estimate-0.28-0.41-1.520.13
Low estimate-0.4-0.55-1.87-1.16
High estimate-0.12-0.18-1.21.32
Year ago EPS-0.61-0.02-1.74-1.52
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts6678
Avg. Estimate20.92M14.28M65.4M157.28M
Low estimate19M2.2M47.2M93.1M
High estimate24.8M26.88M84.43M248.1M
Year ago salesN/AN/A23.03M65.4M
Sales growth (year/est)N/AN/A184.00%140.50%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.53-0.4-0.52-0.54
Actual EPS-0.61-0.02-0.63-0.52
Difference-0.080.38-0.110.02
Surprise %-15.10%95.00%-21.20%3.70%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.28-0.41-1.520.13
7 days ago-0.3-0.4-1.560.12
30 days ago-0.3-0.4-1.560.12
60 days ago-0.32-0.43-1.670.07
90 days ago-0.38-0.43-1.39-0.06
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 days1131
Up last 30 days1131
Down last 7 daysN/AN/AN/AN/A
Down last 30 days222N/A
Growth estimatesCARAIndustrySector(s)S&P 500
Current qtr.54.10%N/AN/AN/A
Next qtr.-1,950.00%N/AN/AN/A
Current year12.60%N/AN/AN/A
Next year108.60%N/AN/AN/A
Next 5 years (per annum)110.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A